| Could maternal perinatal atypical antipsychotic treatments program later metabolic diseases in the offspring? | |
| | |
MedLine Citation:
|
PMID: 21664905 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
An association is established between schizophrenia and the development of metabolic alterations including cardiovascular diseases, type 2 diabetes and obesity. Perinatal insults, such as undernutrition, have been shown to increase the propensity to develop these pathologies, reinforcing the idea that schizophrenia may have a neurodevelopmental origin. Moreover, the use of second generation antipsychotics (SGAs) also known as "atypical" neuroleptics has also been demonstrated to exacerbate metabolic anomalies in patients with schizophrenia. SGAs are able to cross the placental barrier and have been detected in milk from women receiving atypical neuroleptics treatment during the perinatal period. To date, the consequences of such treatment have only been examined on the birth weight and the cognitive capacities of the child from women with schizophrenia, but no data is available concerning the putative long-term effects of SGAs on their body weight and metabolic parameters. We have recently reported that rat offspring from prenatally undernourished mothers exhibit a low birth weight associated with modified sensitivity to clozapine and aripiprazole in adulthood reinforcing the idea that some forms of schizophrenia may be acquired during early development. In view of these observations, the risks of perinatal exposure to SGAs must be weighed against the growing evidence that maternal psychiatric illness poses risks to the fetus/newborn as well as for long-term susceptibility to diseases. Thus, metabolic follow-up of children born from mothers treated by SGAs during the perinatal period will be clearly recommended, in particular if they exhibit alterations of their body weight during this early critical period. |
| | |
Authors:
|
Johann Guillemot; Christine Laborie; Isabelle Dutriez-Casteloot; Michel Maron; Sylvie Deloof; Jean Lesage; Christophe Breton; Didier Vieau |
Related Documents
:
|
3426685 - Ethanol metabolism in alcohol dehydrogenase deficient deermice is mediated by the micro... 104045 - Effect of ethanol on the retention of americium-241 in the baboon liver. 1168205 - Vitamin b6 metabolism in chronic alcohol abuse the effect of ethanol oxidation on hepat... 3881285 - Metabolic effects of alcohol. 8087205 - 2-aminoadipate-2-oxoglutarate aminotransferase isoenzymes in human liver: a plausible p... 2907615 - Pressor response mediated via histamine h1-receptors of the guinea-pig sympathetic gang... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-6-9 |
Journal Detail:
|
Title: European journal of pharmacology Volume: - ISSN: 1879-0712 ISO Abbreviation: - Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-6-13 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 1254354 Medline TA: Eur J Pharmacol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011. Published by Elsevier B.V. |
Affiliation:
|
Equipe Dénutritions Maternelles Périnatales (Unité Environnement Périnatal et Croissance, EA4489), Bâtiment SN4, 2(ème) étage, Université Lille 1, Université Lille-Nord de France, 59 655 Villeneuve d'Ascq cedex, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Multiple signalling pathways underlie the protective effect of levosimendan in cardiac myocytes.
Next Document: The carbohydrate ligands on the host embryo mediate intercellular migration of the parasitic wasp em...